Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.13 USD | +11.88% | +7.62% | +42.50% |
May. 31 | European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower | MT |
May. 31 | Transcript : Adaptimmune Therapeutics plc - Special Call |
Financials (USD)
Sales 2024 * | 42.17M | Sales 2025 * | 41.09M | Capitalization | 289M |
---|---|---|---|---|---|
Net income 2024 * | -170M | Net income 2025 * | -181M | EV / Sales 2024 * | 6.85 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.03 x |
P/E ratio 2024 * |
-10.6
x | P/E ratio 2025 * |
-3.28
x | Employees | 449 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 14.55% |
Latest transcript on Adaptimmune Therapeutics plc
1 day | +11.88% | ||
1 week | +7.62% | ||
1 month | -6.61% | ||
3 months | -28.93% | ||
6 months | +108.41% | ||
Current year | +42.50% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 57 | 07-12-31 | |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 15-02-28 |
Gavin Wood
DFI | Director of Finance/CFO | 54 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | Oct. 31 |
Andrew Allen
BRD | Director/Board Member | 57 | 23-05-31 |
David Mott
CHM | Chairman | 58 | 14-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.13 | +11.88% | 14,923,183 |
24-05-30 | 1.01 | -.--% | 3,923,317 |
24-05-29 | 1.01 | -2.88% | 828,543 |
24-05-28 | 1.04 | -0.95% | 1,090,026 |
24-05-24 | 1.05 | +3.96% | 560,532 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.50% | 289M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ADAP Stock